AbstractsPublication policy

Abstracts

Showing 10 of 70 abstracts

Proinflammatory role of 12(S)-HETE through the activation of the extracellular signal-regulated kinase (ERK) pathway in human leukocytes: implications in obesity-associated inflammation

Titos E, López-Vicario C, Romo M, Casulleras M, Pérez-Romero N, Martínez-Puchol AI, Sánchez B, Flores-Costa R, Alcaraz-Quiles J, Duran-Güell M, Ibarzábal A, Espert JJ, Clària J.

9th European Workshop on Lipid Mediators (9EWLM), 26–28 June 2024, Edinburgh, UK.

Distinguishing clinical profiles in acute-on-chronic liver failure: a comparative analysis of alcohol-related hepatitis versus infection precipitated acute-on-chronic liver failure

Pohl J, Kerbert A, de la Peña-Ramirez C, Walia N, Sanchez C, Kumar P, Zhang IW, Rausch L, Sittner R, Papp M, Caraceni P, Alessandria C, Laleman W, Albillos A, Janicko M, Blasco VMV, Mookerjee RP, Farias A, Pereira G, Torre A, Marciano S, Mattos AZ, Carrilho FJ, Arroyo V, Trebicka J, Moreau R, Clària J, Angeli P, Piano S, Gustot T, Andreola F, Jalan R, Engelmann C.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

Differential impact of proton pump inhibitors, statins, and nonselective beta-blockers on survival in different stages of chronic liver disease

Gu WY, Tornai D, Calleja JC, Krag A, Thorhauge K, Moreau R, Arroyo V, Bajaj J, Praktiknjo M, Schierwagen R, Ginès P, Uschner FE, Jalan R, Clària J, Arumugam M, Coenraad M, Laleman W, Shawcross DL, Papp M, Trebicka J.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

Urinary biomarkers of tubular and glomerular damage predict renal recovery in patients with hepatorenal syndrome-acute kidney injury

Piano S, Dall'Acqua S, de la Peña-Ramirez C, Sanchez C, Aguilar F, Zilio G, Brocca A, Farias A, Papp M, Pereira G, Caraceni P, Torre A, Alessandria C, Gadano A, Laleman W, Mattos AZ, Uschner FE, Albillos A, Bañares R, Janicko M, Blasco VMV, Mookerjee RP, Fernández J, Gustot T, Jalan R, Clària J, Moreau R, Arroyo V, Carrilho FJ, Trebicka J, Angeli P.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

Exploring the potential of human serum albumin to reprogram B cell function

Romero-Grimaldo B, Casulleras M, Duran-Güell M, Contreras BJ, Fernández J, Arroyo V, Moreau R, López-Vicario C, Clària J.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

Extensive characterization of new biomarkers associated with infection and outcome of decompensation of cirrhosis using high throughput metabolomics, lipidomics and cytokinomics

López-Vicario C, de la Peña-Ramirez C, Duran-Güell M, Contreras BJ, Romero-Grimaldo B, Sánchez-Rodríguez MB, Palomino-Echevarria S, Aguilar F, Laleman W, Gómez-Cabrero D, Queiroz Farias A, Marciano S, Fenaille F, Castelli F, Trebicka J, Moreau R, Arroyo V, Rautou PE, Clària J.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

The global prospective observational study to evaluate the role of liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE): Study design, demographics and overall outcome

Gustot T, Bernal W, Fernández J, Diaz JM de la Pena-Ramirez C, Farias A, Zitelli PM, Kuo A, Nissen N, Marciano S, Gadano A, Westbrook R, Bateman R, Rammohan A, Jothimani D, Sudhindran S, Valsan A Ruiz P, Pagano G, Bagulho L, Marques HP, Belli LS, Perricone G, Selzner N, Tsien C, Gallegos-Orozco JF, Kemmer N, Dhanireddy K, Mendizabal M, Pages J, Lindenmeyer C, Eghtesad B, Lucidi V, Elkrief L, Raszeja-Wyszomirska J, Anders M, Nadalin S, Siniscalchi A, Tosetti G, Vinaixa C, Kriss M, Jalal P, Michard B, Angeli P, Castro-Narro G, Boudjema K, Shetty K, den Hoed C, Carone L, Yilmaz S, Mattos AZ, Martin-Mateos R, Brol MJ, Yoshizumi T, Durand F, Radenne S, Te H, Campos-Varela I, Laleman W, Ohira M, Eguchi S, Engelmann C, Braun F, Sinclair M, Bedoya JU, Loinaz C, Perera T, Soin AS, Liu K, Raevens S, Bishop R, Simpson KJ, Akamatsu N, Chien YC, Berlakovich G, Zuluaga JIM, Stein L Tokat Y, Hernaez R, Duvoux C, Saliba F, McCaughan G, Fondevila C, Pomfret E, Rela M, Sundaram V, Claria J, Arroyo V, Valles F, Martínez JC, Izquierdo-Bueno P, Samuel D, Berenguer M, Bosch A, Sanchez C, Polak W, Karvellas C, Trebicka J, Moreau R, Jalan R.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

Linking gut microbiome enterotypes and dysbiosis to liver disease severity and prognosis

Keller MI, Nishijima S, Podlesny D, Kim CY, Robbani SM, Schudoma C, Fullam A, Akanni W, Orakov A, Schmidt TS, Marotta F, Letunic I, Trebicka J, Papp M, Laleman W, Uschner FE, Shawcross DL, Coenraad MJ, Jalan R, Clària J, Kuhn M, Van Rossum T, Bork P.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

Variation of the human microbiome across multiple body sites and temporal dynamics in different stages of decompensated cirrhosis

Gu WY, Broekhoven A, Van Blerk S, Keller MI, Kuhn M, Insonere JLM, Roulet A, Schierwagen R, Alvarez-Silva C, Hercog R, Telzerow A, Ducarmon Q, Zwittink R, Kuijper EJ, Uschner FE, Jalan R, Laleman W, Shawcross DL, Clària J, Arumugam M, Bork P, Papp M, Servant F, Coenraad M, Lelouvier B, Trebicka J.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.

The linoleic acid-derived leukotoxin 9, 10-DiHOME drives immunosuppression in patients with acute-on-chronic liver failure

Contreras BJ, López-Vicario C, Casulleras M, Duran-Güell M, Romero-Grimaldo B, Trebicka, Arroyo V, Clària J.

EASL Congress 2024, European Association for the Study of the Liver (EASL), 5–8 June 2024, Milan, Italy.